Anthropic’s Long-Term Benefit Trust appoints Vas Narasimhan to Board of Directors
Anthropic
Vas Narasimhan joins Anthropic's Board of Directors, appointed by the Long-Term Benefit Trust.Summary
The Anthropic Long-Term Benefit Trust has appointed Vas Narasimhan, CEO of Novartis, to Anthropic's Board of Directors. Narasimhan, a physician-scientist, brings extensive experience in developing and approving novel medicines in highly regulated industries. His appointment is seen as valuable for Anthropic's mission of developing AI responsibly for the long-term benefit of humanity, balancing financial success with its public benefit mission. With this addition, Trust-appointed directors now form a majority on the board, ensuring governance alignment. Narasimhan expressed his honor in joining Anthropic, highlighting AI's potential in healthcare and his commitment to responsible technology deployment.
(Source：Anthropic)